Related Experiment Video
Updated: Apr 19, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
28.1K
[Obesity and cardiovascular risk in children]
Recenti Progressi in Medicina
|December 24, 2014
Summary
Childhood obesity is rising globally, leading to early heart disease risks even in preschoolers. Early intervention and multidisciplinary strategies are crucial for prevention and managing associated health issues.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Health
- Metabolic Disorders
Context:
- Childhood obesity rates have surged globally, with onset at younger ages.
- Obesity is linked to serious complications and cardiovascular risk factors from early childhood.
- Cardiometabolic risks, including fatty liver, appear early in overweight/obese preschoolers.
Purpose:
- To highlight the early onset of cardiometabolic risk factors in childhood obesity.
- To emphasize the need for early prevention and screening of comorbidities.
- To underscore the importance of multidisciplinary approaches in pediatric obesity management.
Summary:
- The ORIGIN study detected cardiometabolic risks like fatty liver in preschoolers with overweight/obesity.
- These risks were present despite short-term excess weight exposure and reduced insulin sensitivity.
- Early cardiometabolic impairments are reversible with lifestyle interventions in children.
Impact:
- Early detection and intervention are vital for preventing long-term health consequences of childhood obesity.
- Multidisciplinary strategies are essential for effective childhood obesity prevention and comorbidity screening.
- Findings support proactive public health initiatives targeting pediatric weight management and metabolic health.
Related Concept Videos
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Coronary Artery Disease I: Introduction
1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Drug Dosing: Obese Patients
351
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
351
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
425
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
425
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
310
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Psychoneuroimmunology: Cardiovascular Disease
724
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
724

